Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
30 Janeiro 2024 - 6:00PM
Business Wire
Inogen, Inc. (Nasdaq: INGN), a medical technology company
offering innovative respiratory products for use in the homecare
setting, today announced that it will report fourth quarter and
full year 2023 financial results after the market closes on
Tuesday, February 27, 2024. On the same day, the Company will host
a conference call at 2:00 p.m. PT / 5:00 p.m. ET.
Individuals interested in listening to the conference call may
do so by dialing:
US domestic callers (877) 841-3961 Non-US
callers (201) 689-8589
Please reference Inogen to join the call. To listen to a live
webcast, please visit the Investor Relations section of Inogen's
website at: http://investor.inogen.com/. This webcast will also be
archived on the website for 6 months.
A replay of the call will be available approximately three hours
after the live webcast ends and will be accessible through March 5,
2024. To access the replay, dial (877) 660-6853 or (201) 612-7415
and reference Conference ID: 13743411.
Inogen has used, and intends to continue to use, its Investor
Relations website, http://investor.inogen.com/, as a means of
disclosing material non-public information and for complying with
its disclosure obligations under Regulation FD. For more
information, visit http://investor.inogen.com/.
About Inogen
Inogen, Inc. (Nasdaq: INGN) is a leading global medical
technology company offering innovative respiratory products for use
in the homecare setting. Inogen supports patient respiratory care
by developing, manufacturing, and marketing innovative
best-in-class portable oxygen concentrators used to deliver
supplemental long-term oxygen therapy to patients suffering from
chronic respiratory conditions. Inogen partners with patients,
prescribers, home medical equipment providers, and distributors to
make its oxygen therapy products widely available allowing patients
the chance to remain ambulatory while managing the impact of their
disease.
For more information, please visit www.inogen.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240130019757/en/
ir@inogen.net
Inogen (NASDAQ:INGN)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Inogen (NASDAQ:INGN)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024